Studies show that OBI infectivity is shaped by both donor and recipient immunity, in which higher donor HBV DNA and low/absent donor anti-HBs increase the risk of infection, while recipient anti-HBs (±anti-HBc) is protective. This evidence concerns the gene KRT88P and infection.